CD152 (CTLA-4) regulates effect or functions of CD8+ T lymphocytes by repressing Eomesodermin

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 883-893

  Hegel, Johannes K ^a,b   Knieke, Karin ^a,b   Kolar, Paula ^b   Reiner, Steven L ^c   Brunner Weinzierl, Monika C ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CD8; Costimulation; Cytotoxicity; Inhibitory receptors; Transcription factors

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EOMESODERMIN; GAMMA INTERFERON; GRANZYME B; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CKROX; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; EOMES PROTEIN, MOUSE; GRANZYME; LEUKOCYTE ANTIGEN; OVALBUMIN; T BOX TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FUNCTION; IN VIVO STUDY; INHIBITION KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GENE EXPRESSION REGULATION; GRANZYMES; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS;

EID: 64049116467     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838770     Document Type: Article

References (35)

1. Sharpe, A. H. and Freeman, G. J., The B7-CD28 superfamily. Nat. Rev. Immunol. 2002. 2: 116-126.
2. Alegre, M. L., Frauwirth, K. A. and Thompson, C. B., T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 2001. 1: 220-228.
3. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B. et al., Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 1993. 151: 3489-3499.
4. van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P. and Davis, S. J., CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 1997. 185: 393-403.
5. Waterhouse, P., Penninger, J. M., Timms, E.,Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B. et al., Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995. 270: 985-988.
6. + T cells. Immunity 1997. 7: 885-895.
7. Calvo, C. R., Amsen, D. and Kruisbeek, A. M., Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 1997. 186: 1645-1653.
8. Leach, D. R., Krummel, M. F. and Allison, J. P., Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996. 271: 1734-1736.
9. Pandiyan, P., Hegel, J. K., Krueger, M., Quandt, D. and Brunner-Weinzierl, M. C., High IFN-{gamma} production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4). J. Immunol. 2007. 178: 2132-2140.
10. + T cells. Eur. J. Immunol. 1998. 28: 3137-3143.
11. + T cell- and IL-2-dependent mechanism. Immunity 1999. 11: 483-493.
12. van Elsas, A., Sutmuller, R. P., Hurwitz, A. A., Ziskin, J., Villasenor, J., Medema, J. P., Overwijk, W. W. et al., Elucidating the autoimmune an antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy. J. Exp. Med. 2001. 194: 481-489.
13. Egen, J. G., Kuhns, M. S. and Allison, J. P., CTLA-4: New insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 2002. 3: 611-618.
14. Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T. et al., Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl. Acad. Sci. USA 2003. 100: 4712-4717.
15. Glimcher, L. H., Townsend, M. J., Sullivan, B. M. and Lord, G. M., Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 2004. 4: 900-911.
16. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005. 6: 1236-1244.
17. + T cell function by the transcription factor Eomesodermin. Science 2003. 302: 1041-1043.
18. Townsend, M. J., Weinmann, A. S., Matsuda, J. L., Salomon, R., Farnham, P. J., Biron, C. A., Gapin, L. et al., T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004. 20: 477-494.
19. Ryan, K., Garrett, N., Mitchell, A. and Gurdon, J. B., Eomesodermin, a key early gene in Xenopus mesoderm differentiation. Cell 1996. 87: 989-1000.
20. Russ, A. P.,Wattler, S., Colledge,W. H., Aparicio, S. A., Carlton,M. B., Pearce, J. J., Barton, S. C. et al., Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature 2000. 404: 95-99.
21. Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P. and Glimcher, L. H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002. 295: 338-342.
22. Jenkinson, S. R., Intlekofer, A. M., Sun, G., Feigenbaum, L., Reiner, S. L. and Bosselut, R., Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation. J. Exp. Med. 2007. 204: 267-272.
23. Bonifaz, L. C., Bonnyay, D. P., Charalambous, A., Darguste, D. I., Fujii, S., Soares, H., Brimnes, M. K. et al., In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 2004. 199: 815-824.
24. Hernandez, J., Aung, S., Redmond, W. L. and Sherman, L. A., Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 2001. 194: 707-717.
25. Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M. et al., Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998. 92: 3780-3792.
26. + TCR-transgenic T cells: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J. Immunol. 2001. 166: 3900-3907.
27. Bachmann, M. F., Waterhouse, P., Speiser, D. E., McKall-Faienza, K., Mak, T. W. and Ohashi, P. S., Normal responsiveness of CTLA-4-deficient antiviral cytotoxic T cells. J. Immunol. 1998. 160: 95-100.
28. Rudd, C. E., The reverse stop-signal model for CTLA4 function. Nat. Rev. Immunol. 2008. 8: 153-160.
29. Schneider, H., Downey, J., Smith, A., Zinselmeyer, B. H., Rush, C., Brewer, J. M., Wei, B. et al., Reversal of the TCR stop signal by CTLA-4. Science 2006. 313: 1972-1975.
30. Schneider, H., Smith, X., Liu, H., Bismuth, G. and Rudd, C. E., CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization. Eur. J. Immunol. 2008. 38: 40-47.
31. + T cell differentiation. J. Immunol. 2006. 177: 7515-7519.
32. Suto, A., Wurster, A. L., Reiner, S. L. and Grusby, M. J., IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 2006. 177: 3721-3727.
33. + T cells for adoptive immunotherapy. Blood 2008. 111: 5326-5333.
34. Hoff, H. and Brunner-Weinzierl, M. C., The tyrosine phosphatase SHP-2 regulates differentiation and apoptosis of individual primary T lymphocytes. Eur. J. Immunol. 2007. 37: 1072-1086.
35. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001. 29: E45.